Live Quote · NASDAQENTAHealthcare· Biotechnology

Enanta Pharmaceuticals, Inc.

$7.62▼ 4.51%($-0.36)
MKT CAP $221.94MNEXT EARNINGS Feb 8, 2027
50%
Bullish
TickerSpark Score
52/100
▌ Mixed
60
Valuation
40
Profitability
60
Growth
72
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ENTA research report →

Analyst Price Target
$20.00+162.5% vs. today

Range $20 – $20

Analyst RatingBuy
14 Buy3 Hold2 Sell

Price Chart

-37.18% · this period
$16.85$12.24$7.62Nov 20May 26Nov 20
52-Week Range1% of range
Low
$7.56
Current
$7.62
High
$17.15